Pediatric non-alcoholic fatty liver disease: Preventive and therapeutic value of lifestyle intervention

doi:10.3748/wjg.15.6017

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 48

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6432)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

598

HTML

5184

Figures (1-2)

414

Tables (1-1)

236

Sum=6432

Dec 28, 2009 (publication date) through Nov 26, 2024

Times Cited of This Article

Times Cited (58)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastroenterol. Dec 28, 2009; 15(48): 6017-6022
Published online Dec 28, 2009. doi: 10.3748/wjg.15.6017

Table 1 Success and failure rates after therapeutic intervention in children with liver-biopsy-proven NAFLD n (%)

	Lifestyle intervention	Vitamin E	Metformin
n	29	25	28
Complete success (all endpoints)	11 (38)	9 (36)	2 (7)
Partial success
Serum ALT normalization	23 (79)	13 (52)	23 (75)
HOMA-IR ≤ 1 restoration	11 (38)	9 (36)	2 (7)
NAS amelioration	19 (65)	17 (68)	16 (57)
Complete failure	4 (14)	8 (32)	2 (7)

NAFLD: Nonalcoholic fatty liver disease; HOMA-IR: Homeostatic model assessment of insulin resistance; NAS: NAFLD activity score; ALT: Alanine transaminase.

Citation: Nobili V, Alisi A, Raponi M. Pediatric non-alcoholic fatty liver disease: Preventive and therapeutic value of lifestyle intervention. World J Gastroenterol 2009; 15(48): 6017-6022
URL: https://www.wjgnet.com/1007-9327/full/v15/i48/6017.htm
DOI: https://dx.doi.org/10.3748/wjg.15.6017